U.S. Markets close in 4 hrs 4 mins

Arena Pharmaceuticals, Inc. (ARNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
24.90-0.21 (-0.84%)
As of 11:56AM EDT. Market open.
People also watch
VVUSOREXARIAKERXAMRN
  • k
    kingcat
    kingcat
    From their recent 10-Q Company filing regarding Lawsuits:-
    A panel of the Ninth Circuit heard oral argument on the appeal on May 4, 2016. On October 26, 2016, the Ninth Circuit panel reversed the District Court’s dismissal of the second consolidated amended complaint and remanded the case back to the District Court for further proceedings. On January 25, 2017, the District Court permitted us to submit a renewed motion to dismiss the second consolidated amended complaint. On February 2, 2017, we filed the renewed motion to dismiss. On February 23, 2017, the lead plaintiff filed his opposition, and on March 2, 2017, we filed our reply. On April 28, 2017, the District Court denied our renewed motion to dismiss. Due to the stage of these proceedings, we are not able to predict or reasonably estimate the ultimate outcome or POSSIBLE LOSES relating to these claims.
  • D
    Dan
    Dan
    How long can a company buy their own stock each day spending $250,000 each day?
  • R
    Reza
    Reza
    Friends, pps propped up thru accounting smoke and mirrors and the 6 IB's that were paid for their services. On Monday Sept 18 55.4% of trades shorted arna. On Tuesday Sept 19 45% of trades went short. This house of cards will come crashing down.
  • k
    kingcat
    kingcat
    People forget the Class Action Lawsuit is not yet over. The 9th Circuit court decision is due anyday now. The settlement will be in the $$ Millions + Legal costs. Now it makes sense as to why they raised all that cash and also why this is trading higher for funds to get out before the news and PPS crash!
  • D
    Dan
    Dan
    Follow the Big Money
    Research and development expenses totaled $17.9 million. General and administrative expenses totaled $7.2 million. Net loss was $23.6 million or $0.77 per share.
    Not A $24 per share company lMO
    And a wopping lost 83% of instituional investment
  • T
    Trader
    Trader
    Inst Ownership Down Huge over past 3 years. Insiders own just 0.26%....No belief in co or it's products
  • J
    Jack
    Jack
    ARNA just needs to add 42.7 million more shares to reach their 6/16/17 authorized share number. Will happen sooner not later.
  • D
    Dan
    Dan
    ARNA just stole 22% of anyone holding the stock by diluting. Just posted a $23.6 million loss and had a 83% drop in financial investment leave.... Are there any clues here? Hummm
  • D
    Dan
    Dan
    More manipulation to keep investors believing but anyone holding this stock for 2 years has it at $20.60 or lower. So this is the best get out point they have No investor will risk this gain sending it lower
  • D
    Dan
    Dan
    Good morning. They are desperately trying to keep it higher. The stock has no buyer except the company. over 83% loss in Institutional investment left. Follow the big money. They got out
  • L
    Lee
    Lee
    If you are looking for novel therapies meeting untreated patient populations you are looking in the WRONG place. This company is 100% about using old technology to apply it to broad market populations.
  • A
    Avi Goldmann
    Avi Goldmann
    Record low volume. No excitement about this pos. PPS not tied to weak company or it's old science behind eight ball delayed pipe.
  • D
    Dan
    Dan
    Dead Rats ::: Shareholder Carl Schwartz had filed suit after the FDA published the briefing documents between the agency and Arena on its website, showing that the agency had concerns about whether lorcaserin would cause cancer in humans. The company's stock price fell by 40 percent in a single day after the dispute became public, court records show.
  • P
    Phineas
    Phineas
    Any one know why last 10Q failed to mention that Klassan is a defendant in a lawsuit? "Defendant Klassen embarked on a deliberately reckless scheme to circumvent the FDA"
  • L
    Larry
    Larry
    Won't they apply funds from recent dilution to Shareholder Class Action Lawsuit ?
  • D
    Dan
    Dan
    A diet drug? Rat Cancer? Yes please buy all you can before they sell out on the shelves.
  • J
    Jay
    Jay
    then there's male lactation and gynecomastia
  • D
    Dan
    Dan
    It Killed rats
    Law360, Los Angeles (October 26, 2016, 5:56 PM EDT) -- The Ninth Circuit on Wednesday revived a proposed class action against Arena Pharmaceuticals alleging the company lied to shareholders about tests for a diet drug, finding that even though the drug was later approved, the company shouldn't have told shareholders testing was going smoothly when it wasn't.
  • Q
    Q
    Q
    Just one small August 2017 filing of ARNA Defense Lawyers in Class Action Lawsuit cost arna shareholders $37,403.50..LOL 3752 words 1 Partner 2 associates 1 paralegal.
  • D
    Dan
    Dan
    Only .26% (that is 1/4 of 1%) held by insiders. 39 million shares outstanding ... Huge amount of institutional investment just left. Follow the Big money and they just left